Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_03073
Species: Mus musculus
Position : chr8:121503787-121504483
Year: 2019
Title: An Nfil3-Zeb2-Id2 pathway imposes Irf8 enhancer switching during cDC1 development.
Genome Build: mm39
Enhancer Type: Enhancer
Condition: Normal
PMID:  31406377
Tissue: bone marrow
Tissue Ontology ID: UBERON:0002371
Cell Source: plasmacytoid dendritic cells
Cell Type: plasmacytoid dendritic cell
Cell Ontology ID: CL:0000784
Experiment Type: Enhancer switching; E-box TF input; endogenous enhancer deletion; lineage-fate analysis
High Throughput Method: ATAC-seq; ChIP-seq; RNA-seq; scRNA-seq; single-cell RNA-seq
Low Throughput Method: CRISPR/endogenous +41 enhancer deletion; retroviral reporter; site-directed mutagenesis; RT-qPCR; flow cytometry
About Target Gene
Target gene : Irf8
About TF
TF name : Tcf4
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
Tcf4 AndrogenReceptor netpath 167
Tcf4 CDO in myogenesis reactome 29
Tcf4 Coregulation of Androgen receptor activity pid 61
Tcf4 Formation of the beta-catenin:TCF transactivating complex reactome 88
Tcf4 ID netpath 38
Tcf4 Regulation of nuclear beta catenin signaling and target gene transcription pid 80
Tcf4 TGF_beta_Receptor netpath 220
Tcf4 Wnt netpath 118
Tcf4 Hs_Corticotropin-releasing_hormone_signaling_pathway_WP2355_90017 wikipathways 41
Enhancer Associated Network
Overlapping Enhancers (mm39) 6 found
Enhancer ID Position Tissue Cell Disease
E_01166 chr8:121503787-121504483 bone marrow dendritic cell progenitor NA
E_01346 chr8:121503787-121504483 bone marrow dendritic cell lineage NA
E_01347 chr8:121503787-121504483 bone marrow dendritic cell lineage NA
E_03105 chr8:121503787-121504483 bone marrow dendritic cell progenitor NA
E_03106 chr8:121503787-121504483 bone marrow conventional dendritic cell precursor NA
E_03107 chr8:121503787-121504483 bone marrow conventional dendritic cell precursor NA
Expression of Target Genes for the Enhancer